Stocks Health care DCGO
NASDAQ · Health careDocGo Inc. (DCGO)
DocGo Inc. brought in $294.7M of revenue over the twelve months to June 30, 2026, down 32.4% from a year earlier. It posted a net loss of $192.4M. Operating cash flow minus capital spending left $29.9M of free cash flow in fiscal 2025. At June 30, 2026 it held $25.2M in cash against $207.4K of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 17, 2026.
Key facts about DocGo Inc.
- Net worth
- DocGo Inc. has a market value (market cap) of $22.3M at the latest share price, and shareholders' equity of $119.1M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $322.2M (-47.7% year on year), with a net loss of $182.4M. Over the 12 months to June 30, 2026: revenue $294.7M, net loss $192.4M.
- Cash flow
- In fiscal 2025 operations brought in $34.5M of cash; after $4.5M of capital spending, free cash flow was $29.9M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 17, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- DocGo Inc.'s next report was expected around November 9, 2026 and is not on file with the SEC yet.
What DocGo Inc. does
DocGo Inc. is registered with the SEC under industry code SIC 8000 (Services-Health Services). Its shares trade on NASDAQ under the ticker DCGO.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $322.2M | -$182.4M | -$1.84 | $29.9M |
| 2024 | $616.6M | $20M | $0.18 | $66.5M |
| 2023 | $624.3M | $6.9M | $0.06 | -$71.8M |
| 2022 | $440.5M | $34.6M | $0.34 | $25.7M |
| 2021 | $318.7M | $23.7M | $0.25 | -$6.8M |
| 2020 | $94.1M | -$14.8M | -$0.25 | -$15M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where DCGO ranks in Health care
Latest SEC filings
What DocGo Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 5, 2026Material agreement8-KDocGo and its subsidiary entered into an amended credit agreement providing new term loan facilities and issued warrants to the lender.
- August 17, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 8.7% to $73.4M versus the same quarter last year; diluted EPS -$0.16 versus -$0.11.
- August 17, 2026
- August 10, 2026Late quarterly report notice NT 10-Q
- July 31, 2026
- July 28, 2026Passive stake changed SCHEDULE 13G/A
- July 2, 2026
- June 18, 2026
- May 11, 2026Quarterly report 10-Q · period to March 31, 2026Revenue fell 21% to $75.6M versus the same quarter last year; diluted EPS -$0.15 versus -$0.09.
- May 11, 2026
What is DCGO worth? A DCF from its reported cash flow
Insider trades
What the people running DocGo Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| May 12, 2026 | Bienstock LeeChief Executive Officer, Director | Shares withheld for tax | 15,644 | $9.2K |
| March 30, 2026 | Bienstock LeeChief Executive Officer, Director | Shares withheld for tax | 18,811 | $10.7K |
| December 15, 2025 | Tendler Ely DGeneral Counsel and Secretary, Director | Sold | 16,850 | $15.3K |
| December 15, 2025 | Rosenberg NormanCFO and Treasurer | Shares withheld for tax | 65,774 | $59.9K |
| December 15, 2025 | Sugrue StephenChief Compliance Officer | Shares withheld for tax | 35,968 | $32.7K |
| December 15, 2025 | Bienstock LeeChief Executive Officer, Director | Shares withheld for tax | 214,131 | $194.9K |
| December 12, 2025 | Travers James MDirector | Received as pay | 150,000 | - |
| December 12, 2025 | Burdiek Michael JDirector | Received as pay | 150,000 | - |
Who owns DCGO
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Insiders
8 insiders reported holding 6,395,763 shares in total, about $1.4M at the last price.
| Holder | Shares |
|---|---|
| Bienstock LeeChief Executive Officer, Director | 2,801,826 |
| Rosenberg NormanCFO and Treasurer | 1,223,571 |
| Burdiek Michael JDirector | 791,560 |
| Sugrue StephenChief Compliance Officer | 636,602 |
| Tendler Ely DGeneral Counsel and Secretary, Director | 258,795 |
| Travers James MDirector | 240,999 |
| Smedra IraDirector | 240,999 |
| Leite EtalvinaDirector | 201,411 |
Questions about DCGO
What does DocGo Inc. do?
DocGo Inc. is a company in the Health care sector, listed on NASDAQ as DCGO. Its shares trade on NASDAQ under the ticker DCGO.
What is DocGo Inc.'s net worth?
DocGo Inc. has a market value (market cap) of $22.3M at the latest share price, and shareholders' equity of $119.1M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is DocGo Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $192.4M on revenue of $294.7M.
How much revenue does DocGo Inc. make?
Over the twelve months to June 30, 2026 DocGo Inc. reported revenue of $294.7M. That is 32.4% less than a year earlier.
When did DocGo Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 17, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the material agreement from October 5, 2026.
When is DocGo Inc.'s next earnings report?
DocGo Inc.'s next report was expected around November 9, 2026 and is not on file with the SEC yet.
Similar companies
Compare DCGO with
Follow DCGO
Get an email when DocGo Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values DocGo Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.